Sold:
#ELIX Elixirr: Disappointing Forward look.
#VLG Venture Life: Mixed update, I may return.
Some #GYM: Reduced fully-invested Book Value position (~10% of pf) as it's a slow burner & dipping.

Buys: (with Stocko backed data):
#PEB Pebble Beach Systems & #IOF Iofina

Elixirr #ELIX
Share Price 480p (-3.6%)

I’ve added again today and may buy another tranche if SP falls further

Reckon both brokers' reduced price guidance is doing the most damage. However, more realistic expectations could ultimately be positive

I’m buying the risk/reward.
Averaging down started.

Elixirr #ELIX
Share Price 516p (-17%)

H1

Fair reasons for a lower valuation.

*Poor 5% organic growth.

*Weak H1 free cash flow.

*Peel Hunt broker sharp downgrade

But a 25% rise in revenue, 29% EBITDA growth and 18% EPS growth remain.

Sell-off looks overdone.
A first time buy.
Worth a trade!

Cheers Stu, it's difficult to lose that much but hopefully for the best. There's been little support for #ELIX this year anyway...

Why Elixirr shares were roiled despite record results:

Revenues and pre-tax profits both up 25% amid strong demand for the company’s artificial intelligence (AI) transformation services

#ELIX $ELIX #ACN $ACN #Investing #Growthstocks

sharesify.com/why-elixirr-...

Great results here. I don’t hold now as they were a victim of the saas-mageddon earlier in the year. I ditched a basket of stocks there including #ELIX

UK companies in the news:

#AAZ #AXS #AZN #BOR #BRES #CRW #CTL #ELIX #GMET #IOF #JD #MFX #NAS #PRTC #RSG #SYNC

Head to Sharesify.com for news, views and analysis

Topped up on #MKS at 359p after today's drop. Funded, as was yesterday's #ELIX purchase at 603p, by a #GYM trim. I like #GYM and will return but it's a slow-building business unless there's a bid.

AI創薬の未来を切り開くElixとAxcelead DDPの共同研究契約締結 #東京都 #千代田区 #AI創薬 #Elix #タンパク質分解誘導剤

株式会社ElixとAxcelead DDPが新たに共同研究契約を締結し、タンパク質分解誘導剤の創出に挑戦。革新的な創薬手法の開発が期待されます。